UNSPSC 51391710: Cimaterol

This classification denotes a beta-adrenergic agonist with the molecular formula C12H17N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZPY8VRF0GB, chemically known as benzonitrile, 2-amino-5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (+-)- but generally known as cimaterol, which bears US NIH Compound Identifier 2755. European Medicines Agency schedules Cimaterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06276MIG.

UNSPSC 51391710 Cimaterol is a Commodity code that covers emergency medical supplies and public health intervention products, though recent state and local solicitations under this code focus heavily on naloxone (opioid-reversal medication) and safe drug deactivation systems rather than cimaterol specifically. Seminole County, Florida and similar public health jurisdictions procure these supplies through competitive bidding to support community health, harm-reduction, and emergency response initiatives. Quantities typical of recent bids run to hundreds or low thousands of units annually, with quarterly delivery schedules to designated facilities. Issuing bodies soliciting under the code include county health departments and community health agencies; procurement is structured as fixed-fee contracts with two-year initial terms and renewal options, and vendors must meet standard compliance requirements including E-Verify, drug-free workplace certification, and specified insurance coverage.

Recent activity centers in Florida. Seminole County released IFB 60459723LAS on June 30, 2026 (due July 26, 2023, per the notice) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly shipments to the Seminole County Community Health Building in Sanford, Florida. No explicit set-aside or disadvantaged-enterprise designations apply. Procurement does not specify a budget range, but vendors must include all shipping and delivery costs in their proposals and may face FEMA compliance requirements. The code shows limited recent activity; the mismatch between the nominal code name (cimaterol) and the products actually being procured (naloxone and deactivation systems) suggests that state and local procurement offices may be tagging these opportunities to an imprecise taxonomy entry or that the code has drifted from its original scope.